The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population

Journal of Human Genetics

Volumn 55, Issue 9, 2010, Pages 600-604

  Onuma, Hiroshi ^a,b   Tabara, Yasuharu ^a,b   Kawamoto, Ryuichi ^a   Shimizu, Ikki ^c   Kawamura, Ryoichi ^a   Takata, Yasunori ^a   Nishida, Wataru ^a   Ohashi, Jun ^d   Miki, Tetsuro ^a,b   Kohara, Katsuhiko ^a   Makino, Hideichi ^e   Osawa, Haruhiko ^a,b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY   (Japan)

^c Ehime Prefectural Hospital   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e Takanoko Hospital   (Japan)

Author keywords

case control study; GCKR; meta analysis; single nucleotide polymorphism; type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; MALE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK; TRIGLYCERIDES;

EID: 77957310400     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.75     Document Type: Article

References (22)

1. Matschinsky, F. M. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45, 223-241 (1996).
2. Van Schaftingen, E. A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate. Eur. J. Biochem. 179, 179-184 (1989).
3. Slosberg, E. E., Desai, U. U., Janelli, B., St Denny, I., Connelly, S., Kaleko, M. et al. Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein. Diabetes 50, 1813-1820 (2001).
4. Farrelly, D., Brown, K. K., Sieman, A., Ren, J., Lira, S. S., Aagan, D. et al. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. Proc. Natl Acad. Sci. USA 96, 14511-14516 (1999).
5. Sparso, T., Andersen, G., Nielsen, T., Burgdorf, K. K., Sjesing, A. A., Pielsen, A. L. et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia 51, 70-75 (2008).
6. Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I., Chen, H. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336 (2007).
7. Vaxillaire, M., Cavalcanti-Proenca, C., Dechaume, A., Tichet, J., Marre, M., Balkau, B. et al. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 57, 2253-2257 (2008).
8. Qi, Q., Wu, Y., Li, H., Loos, R. J., Hu, F. B., Sun, L. et al. Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population. Diabetologia 52, 834-843 (2009).
9. Horikawa, Y., Miyake, K., Yasuda, K., Enya, M., Hirota, Y., Yamagata, K. et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J. Clin. Endocrinol. Metab. 93, 3136-3141 (2008).
10. Hattersley, A. A., Turner, R. R., Cermutt, M. M., Aatel, P., Tanizawa, Y., Chiu, K. C. et al. Linkage of type 2 diabetes to the glucokinase gene. Lancet 339, 1307-1310 (1992).
11. Rose, C. C., Sk, J., Urhammer, S. S., Alumer, C., Borch-Johnsen, K., Jorgensen, T. et al. A-30G4A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites. Diabetes 54, 3026-3031 (2005).
12. Tam, C. H., Ma, R. C., So, W. Y., Wang, Y., Lam, V. K., Germer, S. et al. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents. Diabetes 58, 765-769 (2009).
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 (Suppl 1), S5-S20 (2003).
14. Tabara, Y., Osawa, H., Kawamoto, R., Onuma, H., Shimizu, I., Miki, T. et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 58, 493-498 (2009).
15. Osawa, H., Yamada, K., Onuma, H., Murakami, A., Ochi, M., Kawata, H. et al. The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am. J. Hum. Genet. 75, 678-686 (2004).
16. * 2 allele frequency and allele positivity tables in case-control studies of complex disease genes. Ann. Hum. Genet. 65, 197-206 (2001).
17. Ohashi, J. & Tokunaga, K. The expected power of genome-wide linkage disequilibrium testing using single nucleotide polymorphism markers for detecting a low-frequency disease variant. Ann. Hum. Genet. 66, 297-306 (2002).
18. Orho-Melander, M., Melander, O., Guiducci, C., Perez-Martinez, P., Corella, D., Roos, C. et al. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57, 3112-3121 (2008).
19. Takeuchi, F., Katsuya, T., Chakrewarthy, S., Yamamoto, K., Fujioka, A., Serizawa, M. et al. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia 53, 299-308.
20. Vaxillaire, M., Veslot, J., Dina, C., Proenca, C., Cauchi, S., Charpentier, G. et al. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 57, 244-254 (2008).
21. Weedon, M. M., Nlark, V. V., Jian, Y., Ben-Shlomo, Y., Timpson, N., Ebrahim, S. et al. A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. Am. J. Hum. Genet. 79, 991-1001 (2006).
22. Yasuda, K., Miyake, K., Horikawa, Y., Hara, K., Osawa, H., Furuta, H. et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 40, 1092-1097 (2008).